During the past decade, Indiana Ohio Heart conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indiana Ohio Heart" #1 sponsor was "Alexion" with 2 trials, followed by "HealthCore-NERI" with 2 trials sponsored, "Proteon Therapeutics" with 2 trials sponsored, "Angion Biomedica Corp" with 1 trials sponsored and "Cubist Pharmaceuticals LLC" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana Ohio Heart" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Clinical Accelerator" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator and "Covance" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Indiana Ohio Heart" are "Acute Kidney Injury" (4 trials), "Cardiac Surgery" (3 trials), "Chronic Kidney Disease" (2 trials), "Erythrocyte Transfusion" (2 trials) and "Bloodloss" (1 trials). Many other conditions were trialed in "Indiana Ohio Heart" in a lesser frequency.

Most popular intervention types in "Indiana Ohio Heart" are "Drug" (9 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "PRT-201" (2 trials), "ANG-3777" (1 trials), "AT-III (Human)" (1 trials) and "Ixmyelocel-T" (1 trials). Other intervention names were less common.

The vast majority of trials in "Indiana Ohio Heart" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Indiana Ohio Heart". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Indiana Ohio Heart, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Indiana Ohio Heart, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".